{"id":"glucose-solution","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperglycemia (if overdosed)"},{"rate":null,"effect":"Phlebitis (if administered intravenously)"},{"rate":null,"effect":"Gastrointestinal upset (if administered orally)"}]},"_chembl":{"chemblId":"CHEMBL2108251","moleculeType":"Oligosaccharide"},"_dailymed":{"setId":"1d95c90b-4437-493e-9c12-c1416484df2d","title":"TD GOLD GLUCOSE CONTROL SOLUTION LEVEL 1 SET () [EPS BIO TECHNOLOGY CORP.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Glucose solution is a simple carbohydrate formulation that delivers glucose directly into the bloodstream or gastrointestinal tract, rapidly increasing blood glucose concentration. It is used to treat acute hypoglycemia, provide nutritional support, and maintain blood glucose homeostasis in patients unable to consume food orally or requiring immediate glycemic correction.","oneSentence":"Glucose solution provides exogenous glucose to raise blood glucose levels in hypoglycemic or nutritionally deficient states.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:47:11.413Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute hypoglycemia"},{"name":"Nutritional support in patients unable to consume food orally"},{"name":"Perioperative glucose supplementation"}]},"trialDetails":[{"nctId":"NCT07264543","phase":"PHASE2, PHASE3","title":"Early Methylene Blue in the Microhemodynamics of Septic Patients","status":"RECRUITING","sponsor":"Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva","startDate":"2026-01-09","conditions":"Septic Shock, Hypoperfusion","enrollment":50},{"nctId":"NCT02728635","phase":"NA","title":"Epigenetic Regulation of Human Adipose Tissue Distribution","status":"ACTIVE_NOT_RECRUITING","sponsor":"AdventHealth Translational Research Institute","startDate":"2016-07","conditions":"Obesity","enrollment":27},{"nctId":"NCT04847063","phase":"PHASE1","title":"Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-10-19","conditions":"Peritoneal Mesothelioma, Peritoneal Carcinomatosis, Ovarian Cancer","enrollment":60},{"nctId":"NCT04826341","phase":"PHASE1, PHASE2","title":"A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmonary Small Cell Neuroendocrine Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-09-20","conditions":"HRD Cancer, SCLC, Advanced Solid Tumors","enrollment":120},{"nctId":"NCT05697770","phase":"PHASE3","title":"SODium BICarbonate for Metabolic Acidosis in the ICU","status":"ACTIVE_NOT_RECRUITING","sponsor":"Australian and New Zealand Intensive Care Research Centre","startDate":"2023-04-26","conditions":"Metabolic Acidosis, Shock","enrollment":500},{"nctId":"NCT05139316","phase":"PHASE3","title":"A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa)","status":"COMPLETED","sponsor":"Ultragenyx Pharmaceutical Inc","startDate":"2021-11-08","conditions":"Glycogen Storage Disease Type IA","enrollment":49},{"nctId":"NCT07241559","phase":"NA","title":"Effectiveness of Thoracolumbar Fascia Mobilization and Ultrasound-Guided 5% Dextrose Injection in Chronic Low Back Pain","status":"RECRUITING","sponsor":"Ankara City Hospital Bilkent","startDate":"2025-11-01","conditions":"Chronic Low Back Pain","enrollment":75},{"nctId":"NCT07493785","phase":"PHASE2, PHASE3","title":"Dexmedetomidine for Invasive Ventilation In the NEOnate","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Intercommunal Creteil","startDate":"2026-06-01","conditions":"Invasive Ventilation, Infant Pain, Infant Discomfort","enrollment":246},{"nctId":"NCT03994471","phase":"PHASE3","title":"Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.","status":"RECRUITING","sponsor":"Iperboreal Pharma Srl","startDate":"2022-12-14","conditions":"End Stage Renal Disease","enrollment":170},{"nctId":"NCT07480967","phase":"NA","title":"Comparison of Platelet-Rich Plasma and Prolotherapy for Plantar Fasciitis","status":"NOT_YET_RECRUITING","sponsor":"Bangladesh Medical University","startDate":"2026-04-01","conditions":"Planter Fasciitis","enrollment":68},{"nctId":"NCT06301880","phase":"PHASE3","title":"Effect of Topically-applied Milrinone or Nitroglycerin on Internal Mammary Artery Free Flow","status":"COMPLETED","sponsor":"Damascus University","startDate":"2022-01-01","conditions":"Internal Mammary Artery Syndrome, Vasodilation","enrollment":46},{"nctId":"NCT07479693","phase":"NA","title":"Comparison of Hyaluronic Acid, Injectable Platelet-Rich Fibrin, and Prolotherapy in TMJ Arthrocentesis","status":"COMPLETED","sponsor":"Ondokuz Mayıs University","startDate":"2025-01-01","conditions":"Temporomandibular Joint Pain, Arthrocentesis","enrollment":36},{"nctId":"NCT05962606","phase":"PHASE2","title":"Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.","status":"COMPLETED","sponsor":"Aptarion Biotech AG","startDate":"2024-02-02","conditions":"Community-acquired Pneumonia","enrollment":150},{"nctId":"NCT05931575","phase":"PHASE2","title":"Safety, Tolerability and Symptomatic Efficacy of the ROCK-Inhibitor Fasudil in Patients With Parkinson's Disease","status":"RECRUITING","sponsor":"Technical University of Munich","startDate":"2023-09-11","conditions":"Idiopathic Parkinson´s Disease","enrollment":75},{"nctId":"NCT07018180","phase":"NA","title":"Interventional Clinical Trial Evaluating COVER PATCH CAPTEUR PROTECT Support Solutions for Continuous Glucose Monitoring Sensors in Patients With Diabetes","status":"RECRUITING","sponsor":"CAPTEUR PROTECT","startDate":"2025-12-05","conditions":"Diabetes","enrollment":194},{"nctId":"NCT06671587","phase":"PHASE4","title":"iGlarLixi CGM Study in Chinese T2D Individuals After OADs","status":"RECRUITING","sponsor":"Sanofi","startDate":"2024-12-10","conditions":"Type 2 Diabetes (T2D)","enrollment":678},{"nctId":"NCT05159427","phase":"PHASE1","title":"Pharmacokinetic Study of Single-Dose Modified Release Glipizide in Healthy Volunteers","status":"RECRUITING","sponsor":"University of Michigan","startDate":"2022-03-15","conditions":"Human Gastrointestinal Physiology Data","enrollment":40},{"nctId":"NCT07427654","phase":"NA","title":"Determination of the Glycemic Index of Products Varying in Levels of Refined and Whole Grain Corn","status":"COMPLETED","sponsor":"PepsiCo Global R&D","startDate":"2026-01-08","conditions":"Glycemic Index, Glycemic Load","enrollment":29},{"nctId":"NCT07469072","phase":"PHASE2","title":"Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in the Intensive Care Unit (ICU)","status":"NOT_YET_RECRUITING","sponsor":"Zhujiang Hospital","startDate":"2026-02-25","conditions":"Continuous Renal Replacement Therapy (CRRT)","enrollment":92},{"nctId":"NCT06469970","phase":"PHASE2","title":"Evolution of the Initial Distribution Volume of Glucose in the Severe Burned Adults","status":"RECRUITING","sponsor":"Centre Hospitalier Régional Metz-Thionville","startDate":"2024-11-28","conditions":"Burns, Intensive Care, Emergencies","enrollment":15},{"nctId":"NCT05275686","phase":"PHASE2","title":"Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)","status":"RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2022-04-20","conditions":"Eustachian Tube Dysfunction","enrollment":80},{"nctId":"NCT04895358","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-06-18","conditions":"Breast Neoplasms","enrollment":340},{"nctId":"NCT06704672","phase":"NA","title":"Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2025-04-14","conditions":"Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus","enrollment":270},{"nctId":"NCT04805242","phase":"NA","title":"Effects of Dextrose Prolotherapy in Rotator Cuff Disease","status":"COMPLETED","sponsor":"Istanbul University","startDate":"2021-03-18","conditions":"Rotator Cuff Disease","enrollment":60},{"nctId":"NCT05116189","phase":"PHASE3","title":"Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-12-13","conditions":"Ovarian Cancer, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms","enrollment":643},{"nctId":"NCT07450469","phase":"","title":"Field Study on Intravenous Iloprost for Treatment of Severe Frostbite at High Altitude","status":"NOT_YET_RECRUITING","sponsor":"Institute of Mountain Emergency Medicine","startDate":"2026-05","conditions":"Frostbite, Altitude, Field Physician Care","enrollment":10},{"nctId":"NCT07118891","phase":"PHASE1, PHASE2","title":"Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause","status":"RECRUITING","sponsor":"AbCellera Biologics Inc.","startDate":"2025-06-23","conditions":"Vasomotor Symptoms Associated With Menopause, Healthy Volunteers","enrollment":136},{"nctId":"NCT03847428","phase":"PHASE3","title":"Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2019-04-29","conditions":"Hepatocellular Carcinoma","enrollment":908},{"nctId":"NCT07451561","phase":"NA","title":"Role of Combination Therapy of Glucose Insulin Potassium Infusion (GIK), Intravenous Hydrocortisone and Oral Sevelamer in Treatment of Acute Aluminum Phosphide Poisoned Cases Admitted to Intensive Care Unit (ICU) at Sohag University Hospitals.","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2026-03","conditions":"Acute Aluminum Phosphide Poisoned Cases","enrollment":74},{"nctId":"NCT07449364","phase":"NA","title":"Allogeneic Human Mesenchymal Stem Cell Infusion for Frailty Patient","status":"COMPLETED","sponsor":"Daewoong Group Indonesia","startDate":"2025-03-24","conditions":"Frailty in Older Adults","enrollment":10},{"nctId":"NCT05304715","phase":"PHASE2","title":"Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection","status":"COMPLETED","sponsor":"Hellenic Institute for the Study of Sepsis","startDate":"2022-04-13","conditions":"Clostridioides Difficile Infection, Stool Microbiome, Organ Dysfunction Syndrome","enrollment":44},{"nctId":"NCT05279937","phase":"PHASE3","title":"The Ultrasound-Guided Dextrose Prolotherapy in Ehlers-Danlos Syndrome Patients","status":"NOT_YET_RECRUITING","sponsor":"Tulane University","startDate":"2026-06","conditions":"Ehlers-Danlos Syndrome, Low Back Pain, Sacroiliac Instability","enrollment":40},{"nctId":"NCT05674799","phase":"NA","title":"NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2023-04-08","conditions":"Overweight or Obesity","enrollment":403},{"nctId":"NCT05832034","phase":"PHASE2, PHASE3","title":"Add-on Intravenous Immunoglobulins in Early Myositis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2021-09-13","conditions":"Inflammatory Myopathy, Idiopathic, Dermatomyositis, Antisynthetase Syndrome","enrollment":44},{"nctId":"NCT06393049","phase":"NA","title":"Microdialysis and Jugular Bulb Glucose Profiles During Hyperglycaemic Clamping in Patients With Severe Acute Brain Injury","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2024-05-08","conditions":"Acute Brain Injury","enrollment":14},{"nctId":"NCT05125809","phase":"PHASE2, PHASE3","title":"Setrusumab vs Placebo for Osteogenesis Imperfecta","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ultragenyx Pharmaceutical Inc","startDate":"2022-02-21","conditions":"Osteogenesis Imperfecta","enrollment":183},{"nctId":"NCT07428512","phase":"NA","title":"Comparison of the Effectiveness of 5% and 10% Dextrose Treatments in Patients With Chronic Shoulder Pain: Ultrasound-Guided Perineural Injection","status":"COMPLETED","sponsor":"Ankara City Hospital Bilkent","startDate":"2025-07-09","conditions":"Chronic Shoulder Pain","enrollment":120},{"nctId":"NCT05174507","phase":"PHASE2","title":"Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes","status":"WITHDRAWN","sponsor":"University Hospital, Basel, Switzerland","startDate":"2022-06-24","conditions":"Postprandial Hypoglycemia","enrollment":""},{"nctId":"NCT05225961","phase":"PHASE4","title":"ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2022-05-01","conditions":"Acute Ischemic Stroke","enrollment":240},{"nctId":"NCT06242847","phase":"","title":"Role of Insulin Action in Psoriasis Pathogenesis","status":"TERMINATED","sponsor":"Columbia University","startDate":"2024-02-02","conditions":"Psoriasis, Plaque Psoriasis, Insulin Resistance","enrollment":10},{"nctId":"NCT06295640","phase":"NA","title":"Relative Contribution of Brain Insulin Action for Postprandial Metabolism","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Ulm","startDate":"2024-03-18","conditions":"Glucose Metabolism Disorders","enrollment":31},{"nctId":"NCT07406477","phase":"PHASE2","title":"The PROTECT-HIE Trial","status":"NOT_YET_RECRUITING","sponsor":"University of Alberta","startDate":"2026-05-01","conditions":"Hypoxic-ischemic Encephalopathy (HIE)","enrollment":40},{"nctId":"NCT06137014","phase":"PHASE1, PHASE2","title":"Fortified Oral Rehydration Therapy for Pediatric Diarrhea","status":"RECRUITING","sponsor":"Paul A Breslin","startDate":"2024-06-01","conditions":"Acute Gastroenteritis","enrollment":72},{"nctId":"NCT07105540","phase":"PHASE4","title":"Comparison of Injection Techniques in Carpal Tunnel Syndrome","status":"COMPLETED","sponsor":"Ankara Etlik City Hospital","startDate":"2025-08-05","conditions":"Carpal Tunnel Syndrome","enrollment":53},{"nctId":"NCT07167693","phase":"PHASE1, PHASE2","title":"Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes","status":"RECRUITING","sponsor":"David K Carroll","startDate":"2025-12-19","conditions":"Diabetes (DM), Diabetic Ketoacidosis, Ketosis Prone Diabetes","enrollment":60},{"nctId":"NCT07403604","phase":"PHASE1","title":"Effect of Insulin Lowering on Lipogenesis","status":"NOT_YET_RECRUITING","sponsor":"Columbia University","startDate":"2026-04","conditions":"Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease","enrollment":25},{"nctId":"NCT04739761","phase":"PHASE3","title":"A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2021-06-22","conditions":"Breast Cancer","enrollment":506},{"nctId":"NCT07399145","phase":"NA","title":"Comparison of Prolotherapy and Rehabilitation Treatments in Low Back Pain (CPRTLBP)","status":"COMPLETED","sponsor":"Balnear and Rehabilitation Sanatorium Techirghiol","startDate":"2025-04-01","conditions":"Low Back Pain","enrollment":84},{"nctId":"NCT05082259","phase":"PHASE1","title":"ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab","status":"RECRUITING","sponsor":"Institute of Cancer Research, United Kingdom","startDate":"2022-03-02","conditions":"Advanced Cancer, Cervical Cancer, Triple Negative Breast Cancer","enrollment":61},{"nctId":"NCT07079930","phase":"PHASE1","title":"Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers","status":"RECRUITING","sponsor":"Hadassah Medical Organization","startDate":"2025-12-11","conditions":"Healthy Volunteers","enrollment":10},{"nctId":"NCT03715517","phase":"NA","title":"Spinal Anesthesia For Enhanced Recovery After Liver Surgery","status":"RECRUITING","sponsor":"University of Manitoba","startDate":"2018-10-04","conditions":"Hepatectomy, Pain, Postoperative, Liver Neoplasms","enrollment":128},{"nctId":"NCT07389837","phase":"NA","title":"Maple Syrup Carbohydrate Dose-Response on 20-km Cycling Time-Trial Performance","status":"NOT_YET_RECRUITING","sponsor":"Université de Montréal","startDate":"2026-02-01","conditions":"Exercise, Endurance Cycling Performance, Carbohydrate Intolerance","enrollment":32},{"nctId":"NCT03953677","phase":"PHASE3","title":"Evaluation of the Effect of Dexmedetomidine on Phenylephrine Response During Refractory Septic Shock","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2019-10-27","conditions":"Septic Shock, Vasopressor Resistance","enrollment":32},{"nctId":"NCT03040999","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2017-04-05","conditions":"Head and Neck Neoplasms","enrollment":804},{"nctId":"NCT06532240","phase":"PHASE3","title":"Methylene Blue for the Treatment of Septic Shock","status":"COMPLETED","sponsor":"Northern Jiangsu People's Hospital","startDate":"2024-08-05","conditions":"Septic Shock","enrollment":88},{"nctId":"NCT03635567","phase":"PHASE3","title":"Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2018-10-25","conditions":"Cervical Cancer","enrollment":617},{"nctId":"NCT07189091","phase":"PHASE4","title":"CReep and Maintenance flUid Sodium Chloride ADministration rEduction in cRitically Ill adultS","status":"RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2025-10-07","conditions":"Critical Care, Intensive Care, Fluid Accumulation, Fluid and Electrolyte Imbalance","enrollment":640},{"nctId":"NCT04158674","phase":"PHASE3","title":"Interest of Levosimendan in Reducing Weaning Failures of ExtraCorporeal Life Support - ECLS","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2020-02-24","conditions":"Acute Decompensated Heart Failure","enrollment":82},{"nctId":"NCT07381621","phase":"","title":"Perineural Dextrose Versus Local Anesthetic Injections in Knee Osteoarthritis","status":"NOT_YET_RECRUITING","sponsor":"Ankara Training and Research Hospital","startDate":"2026-02","conditions":"Knee Osteoarthritis","enrollment":86},{"nctId":"NCT07366710","phase":"NA","title":"Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PET","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2024-11-05","conditions":"Glucose Metabolism, NAFLD (Nonalcoholic Fatty Liver Disease)","enrollment":36},{"nctId":"NCT07371221","phase":"NA","title":"Ultrasound-Guided Dextrose Hydrodissection of the Median Nerve","status":"COMPLETED","sponsor":"Dr. Nafiz Korez Sincan State Hospital","startDate":"2024-06-17","conditions":"Carpal Tunnel Syndrome (CTS)","enrollment":37},{"nctId":"NCT04266730","phase":"PHASE1","title":"Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Concurrently With Pembrolizumab","status":"NOT_YET_RECRUITING","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2026-02-22","conditions":"Squamous Cell Lung Cancer, Squamous Non-small Cell Lung Cancer, Squamous Cell Carcinoma of Head and Neck","enrollment":6},{"nctId":"NCT04623502","phase":"NA","title":"An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2019-09-30","conditions":"Kidney Cancer, Renal Cell Carcinoma, Clear Cell Carcinoma","enrollment":600},{"nctId":"NCT07373834","phase":"NA","title":"Tirzepatide and Muscle Outcomes in Obesity","status":"RECRUITING","sponsor":"University Medical Centre Ljubljana","startDate":"2026-01","conditions":"Obesity (Disorder)","enrollment":30},{"nctId":"NCT05477134","phase":"NA","title":"Arginine Metabolism in Youth With Type 2 Diabetes","status":"RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2023-02-06","conditions":"Type 2 Diabetes","enrollment":30},{"nctId":"NCT07361640","phase":"NA","title":"DiaMester Pilot RCT: E-health Lifestyle Program for Type 2 Diabetes","status":"RECRUITING","sponsor":"Oslo University Hospital","startDate":"2026-01-14","conditions":"Diabetes Mellitus, Type 2","enrollment":99},{"nctId":"NCT07360249","phase":"NA","title":"Glucose-fructose Ratio Pilot","status":"RECRUITING","sponsor":"University of Bath","startDate":"2026-01-14","conditions":"Exercise Metabolism","enrollment":10},{"nctId":"NCT07355712","phase":"NA","title":"Combined Effect of Prolotherapy and Personalized Physical Activity on Knee Osteoarthritis Progression","status":"COMPLETED","sponsor":"Gadjah Mada University","startDate":"2024-07-10","conditions":"Prolotherapy","enrollment":74},{"nctId":"NCT07352150","phase":"NA","title":"Undiluted and Diluted Nutrition","status":"NOT_YET_RECRUITING","sponsor":"John Paul II Catholic University of Lublin","startDate":"2026-02-02","conditions":"Critical Illness, Gastro Intestinal Surgery, Enteral Feeding Intolerance","enrollment":80},{"nctId":"NCT01851694","phase":"NA","title":"Beta-cell Response to Incretin Hormones in Cystic Fibrosis","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2013-05","conditions":"Cystic Fibrosis, Pancreatic Insufficiency","enrollment":45},{"nctId":"NCT03977233","phase":"PHASE2","title":"Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer","status":"RECRUITING","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2019-06-12","conditions":"Pancreatic Ductal Adenocarcinoma (PDAC), Cancer of Pancreas, Pancreatic Cancer, Adult","enrollment":45},{"nctId":"NCT06988228","phase":"NA","title":"The Effects of 15% Dextrose Solution on Pain and Range of Motion in the Hemiplegic Shoulder","status":"COMPLETED","sponsor":"Istanbul Physical Medicine Rehabilitation Training and Research Hospital","startDate":"2024-12-24","conditions":"Hemiplegic Shoulder Pain, Stroke","enrollment":40},{"nctId":"NCT07326865","phase":"NA","title":"Hepatic Gene Response to Intravenous Glucose in Obese Patients With and Without MASLD Undergoing Bariatric Surgery","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2025-11-12","conditions":"MASLD","enrollment":40},{"nctId":"NCT06030609","phase":"PHASE3","title":"The Comparison Between Ringer Lactate Solution and Normal Saline With Dextrose Water in Post-Operative Period of Kidney Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"King Chulalongkorn Memorial Hospital","startDate":"2024-09-01","conditions":"Electrolyte Imbalance, Kidney Transplant; Complications","enrollment":159},{"nctId":"NCT05729282","phase":"PHASE1","title":"Glycemic Effect of Diazoxide in NAFLD","status":"COMPLETED","sponsor":"Columbia University","startDate":"2023-08-01","conditions":"Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease","enrollment":24},{"nctId":"NCT07020715","phase":"PHASE2","title":"A Phase IIa Study of Vitamin D3 Tolerogenic Dendritic Cells (tolDC) for Multiple Sclerosis","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2026-03-01","conditions":"Multiple Sclerosis","enrollment":14},{"nctId":"NCT07149610","phase":"NA","title":"Connected Care for Type 2 Diabetes Self-Management","status":"RECRUITING","sponsor":"Marche Region Regional Health Agency","startDate":"2025-10-13","conditions":"Diabetes Type 2","enrollment":388},{"nctId":"NCT07286981","phase":"NA","title":"Glycemic Index of Date Cultivars and Date-based Products","status":"COMPLETED","sponsor":"King Saud University","startDate":"2024-08-16","conditions":"Glycaemic Response Measurements","enrollment":40},{"nctId":"NCT07309809","phase":"NA","title":"Portrait Mobile Monitoring Solution V2.0 External Evaluation","status":"NOT_YET_RECRUITING","sponsor":"GE Healthcare","startDate":"2026-03","conditions":"Monitoring","enrollment":50},{"nctId":"NCT04986072","phase":"PHASE2","title":"Sodium Nitroprusside in Early Course Schizophrenia","status":"TERMINATED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2022-03-14","conditions":"Schizophrenia, Schizoaffective Disorder","enrollment":1},{"nctId":"NCT07308457","phase":"NA","title":"Enhanced Molecular Microbiological Surveillance Versus Ceftriaxone Prophylaxis in Hematopoietic Cell Transplant Patients","status":"RECRUITING","sponsor":"Pomeranian Medical University Szczecin","startDate":"2024-09-01","conditions":"Incidence of Infectious Diseases","enrollment":100},{"nctId":"NCT06942195","phase":"NA","title":"Effects of Calcium on Gut Functions and Blood Glucose in Humans With Type 2 Diabetes","status":"RECRUITING","sponsor":"University of Adelaide","startDate":"2025-05-22","conditions":"T2DM","enrollment":8},{"nctId":"NCT07198100","phase":"NA","title":"tVNS, Motivation, and Insulin Sensitivity","status":"RECRUITING","sponsor":"University of Bonn","startDate":"2025-10-10","conditions":"Major Depressive Disorder (MDD)","enrollment":120},{"nctId":"NCT06835491","phase":"PHASE3","title":"Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac Arrest With Initial Shockable Rhythm","status":"RECRUITING","sponsor":"Versailles Hospital","startDate":"2025-11-06","conditions":"Ventricular Arrhythmias and Cardiac Arrest","enrollment":674},{"nctId":"NCT07296718","phase":"PHASE4","title":"Single Vs Multi-strain Probiotics for Preterm Neonates","status":"COMPLETED","sponsor":"Madiha, MPhil","startDate":"2023-05-15","conditions":"Necrotizing Enterocolitis of Newborn, Sepsis Newborn, Growth","enrollment":249},{"nctId":"NCT06417125","phase":"PHASE4","title":"Intranasal Dexmedetomidine Versus Oral Midazolam Premedication for Postoperative Negative Behavior Changes in Children","status":"COMPLETED","sponsor":"Fujian Provincial Hospital","startDate":"2024-05-22","conditions":"Behavior Problem","enrollment":324},{"nctId":"NCT07150819","phase":"NA","title":"A Multidisciplinary Perioperative Pain Management","status":"WITHDRAWN","sponsor":"China-Japan Friendship Hospital","startDate":"2022-07-01","conditions":"Anorectal Surgery, Pain Management","enrollment":""},{"nctId":"NCT06441331","phase":"PHASE1","title":"Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors","status":"RECRUITING","sponsor":"ITM Solucin GmbH","startDate":"2025-09-26","conditions":"Somatostatin Receptor Positive, NETs, Lymphoma","enrollment":20},{"nctId":"NCT03952637","phase":"PHASE1, PHASE2","title":"A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis","status":"RECRUITING","sponsor":"National Human Genome Research Institute (NHGRI)","startDate":"2019-08-19","conditions":"Lysosomal Diseases, Gangliosidosis, GM1","enrollment":54},{"nctId":"NCT06880614","phase":"NA","title":"Effect of Acute Protein Supplementation in Diabetic Patients","status":"COMPLETED","sponsor":"University of Malaya","startDate":"2025-06-01","conditions":"Diabetes Mellitus Type 2","enrollment":20},{"nctId":"NCT07147010","phase":"NA","title":"Evaluation of Correlations Between Volatile Organic Compounds and Venous Blood Glucose in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"DCB Research AG","startDate":"2024-10-01","conditions":"Type 2 Diabetes","enrollment":20},{"nctId":"NCT03608033","phase":"PHASE3","title":"Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy","status":"TERMINATED","sponsor":"Omeros Corporation","startDate":"2018-04-05","conditions":"IgA Nephropathy","enrollment":360},{"nctId":"NCT03039673","phase":"PHASE2","title":"MIROCALS: Modifying Immune Response and OutComes in ALS","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2017-06-19","conditions":"Amyotrophic Lateral Sclerosis","enrollment":304},{"nctId":"NCT06170905","phase":"NA","title":"Whey Protein Pre-load and Postprandial Glycemia in Pregnancy","status":"COMPLETED","sponsor":"University of Ulm","startDate":"2024-02-01","conditions":"Pregnancy, Postprandial Glycemia","enrollment":21},{"nctId":"NCT06776094","phase":"NA","title":"Physical Activity and Insulin Sensitivity Dynamics","status":"RECRUITING","sponsor":"University of Copenhagen","startDate":"2025-05-05","conditions":"Insulin Sensitivity","enrollment":8},{"nctId":"NCT07245121","phase":"NA","title":"Perineural Prolotherapy in Chronic Knee Osteoarthritis Pain.","status":"RECRUITING","sponsor":"National and Kapodistrian University of Athens","startDate":"2025-11-24","conditions":"Chronic Pain, Perineural Analgesia, Prolotherapy","enrollment":60},{"nctId":"NCT06638190","phase":"NA","title":"Influence of the Fruit Matrix on Glucose and Insulin Responses After the Intake of Orange Juice in Healthy Human Males","status":"COMPLETED","sponsor":"María-Teresa García-Conesa","startDate":"2024-10-21","conditions":"Healthy Nutrition","enrollment":25},{"nctId":"NCT06154538","phase":"PHASE2","title":"Immune Checkpoint Inhibitors + Chemotherapy Versus Chemotherapy in the Neoadjuvant Treatment of Locally Advanced Colorectal Cancer","status":"RECRUITING","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2023-11-01","conditions":"Locally Advanced Colorectal Carcinoma","enrollment":170},{"nctId":"NCT07251504","phase":"NA","title":"Mitochondrial Metabolism and Oxidative Stress in Function of the Physical Exercise and Nutritional Counseling in T2DM","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cadiz","startDate":"2022-03-10","conditions":"Diabetes Mellitus, Type 2","enrollment":146},{"nctId":"NCT06706284","phase":"PHASE4","title":"Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes","status":"RECRUITING","sponsor":"Marzieh Salehi","startDate":"2025-04-11","conditions":"Spinal Cord Injuries, Type 2 Diabetes","enrollment":50}],"_emaApprovals":[],"_faersSignals":[{"count":3,"reaction":"PYREXIA"},{"count":2,"reaction":"ABDOMINAL DISTENSION"},{"count":2,"reaction":"ATELECTASIS"},{"count":2,"reaction":"DEATH"},{"count":2,"reaction":"DIARRHOEA"},{"count":2,"reaction":"DIZZINESS"},{"count":2,"reaction":"FATIGUE"},{"count":2,"reaction":"HAEMOGLOBIN DECREASED"},{"count":2,"reaction":"MEDICATION ERROR"},{"count":2,"reaction":"NAUSEA"}],"_approvalHistory":[],"publicationCount":2736,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Dextrose","Glucose 20%","Dextrose Gel","Glucote","glucose 5%"],"phase":"marketed","status":"active","brandName":"Glucose solution","genericName":"Glucose solution","companyName":"University of Sao Paulo","companyId":"university-of-sao-paulo","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Glucose solution provides exogenous glucose to raise blood glucose levels in hypoglycemic or nutritionally deficient states. Used for Acute hypoglycemia, Nutritional support in patients unable to consume food orally, Perioperative glucose supplementation.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}